We investigated misclassification rates, sensitivity, and specificity of self-reported cigarette smoking through serum cotinine concentration (liquid chromatography tandem mass spectrometry) among 287 adult survivors of childhood cancer. Overall, 2.5-6.7% and 19.7-36.9% of the selfreported never and past smokers had cotinine levels indicative of active smoking. Sensitivity and specificity of self-reported smoking were 57.5-67.1% and 96.6-99.2%. Misclassification was associated with younger age (OR = 3.2; 95% CI = 1.4-7.4), male (OR = 2.1; 95% CI = 1.1-4.0), and past (OR = 2.7; 95% CI = 1.3-5.8) or current (OR = 2.6; 95% CI = 1.0-6.6) marijuana use. After adjusting for tobacco-related variables, current marijuana use remained a significant risk for misclassification. Clinicians/researchers should consider bio-verification to measure smoking status among survivors.
your entire life?" and "Do you smoke cigarette now?" Consistent with our previous study, 6 these two items were used to classify survivors into three subgroups: never smokers (<100 cigarettes over lifetime; n = 105), past smokers (≥100 cigarettes over lifetime, but report no current smoking; n = 111), and current smokers (≥100 cigarettes over lifetime, and report current smoking; n = 71). Oversampling the current and past smokers allowed sufficient sample sizes for analysis.
Participants provided a research blood sample during medical assessments. Serum cotinine concentrations were quantified by liquid chromatography tandem mass spectrometry analysis. 7 Active smoking status was classified by race-/ethnicity-specific cotinine thresholds. 8 The protocol was approved by institutional review board, and participants provided written informed consent.
Misclassifications were calculated by under-and over-reporting.
Under-reporting rate was defined as the percentage of self-reported never and past cigarette smokers who were bio-verified as active smokers. Over-reporting rate was defined as the percentage of self-reported current cigarette smokers who were bio-verified as nonsmokers. Using cotinine assay as the gold standard, validity (sensitivity, specificity, false positive, and false negative) of self-reported smoking was calculated. For current smokers, misclassification and validity were evaluated by light (≤10 cigarettes per day) and heavy smokers (>10 cigarettes per day). 9 Bivariate analysis was performed to identify factors associated with misclassifications. Variables with P-value < 0.1 were selected into logistic regression analyses (Model 1: combined under-and overreporting; Models 2a-2c: under-reporting only). Factors under consideration included age at evaluation, sex, race/ethnicity, education, marital status, health insurance status, annual household income, years since diagnosis, received any chemotherapy and/or radiotherapy, social desirability, 10 and marijuana use. Marijuana use was self-reported and categorized as never, past, and current use. Because smokeless tobacco (e.g., chewing and snuff), 11 combustible tobacco (e.g., cigar and pipe), 12 and secondhand smoke 13 contribute to cotinine concentration, we developed Model 2b by excluding participants who were current users of smokeless tobacco or cigars/pipes, and Model 2c by further excluding those who were exposed to secondhand smoke from Model 2b.
RESULTS
Participants' age at evaluation, sex, and race/ethnicity were balanced among three self-reported smoking groups (Ps > 0.05; Supplementary Table S1 ). Based on different models controlling for potential effects of smokeless tobacco, cigar/pipe, and secondhand smoke on misclassifications (Table 1) , 2.5-6.7% of the self-reported never smokers and 19.7-36.9% of the self-reported past smokers were classified as active smokers, indicating under-reporting, whereas 4.5-8.5% of the selfreported current smokers were classified as nonsmokers, indicating over-reporting. Without adjusting for tobacco-related variables, sensitivity and specificity for self-reports were 57.5% and 96.6%. After adjustment, sensitivity and specificity were 60.0-67.1% and 98.1-99.2%. For current light smokers, misclassification rate was 14.3%; sensitivity and specificity were 58.1% and 88.2%. For current heavy smokers, misclassification rate was 0%; sensitivity and specificity were 56.9% and 100%.
When combining under-and over-reporting groups (Model 1; Table 2 ), misclassification was significantly associated with younger age (OR = 3.2; 95% CI = 1.4-7.4), male sex (OR = 2.1; 95% CI = 1.1-4.0), and past (OR = 2.7; 95% CI = 1.3-5.8) or current (OR = 2.6; 95% CI = 1.0-6.6) marijuana use. Similar results were found in the under-reporting group (Model 2a; Table 2 ). However, when smokeless tobacco users, cigar/pipe users, and those exposed to secondhand smoke were excluded (Models 2b/2c; Table 2 ), current marijuana use elevated the odds of misclassification by fivefold.
DISCUSSION
Up to 7% of self-reported never smokers and 37% of past smokers were bio-verified as active smokers. Our misclassification rates are higher than those in the general population (<1% in the United States and 2.6% in England), 14 but are significantly lower than childhood cancer survivors (80%) who participated in a telephone-based cessation intervention. 15 This discrepancy may indicate differences in study design (e.g., intervals between survey completion and serum sample collection), confounding by other tobacco-related products, and maladaptive health behaviors (e.g., marijuana use). Interestingly, 4.5-8.5% of current smokers were classified as over-reporting. This does not necessarily indicate an inaccurate cotinine assay, but suggests that, first, because of the time interval from at-home survey completion to the collection of blood samples in clinic some survivors may have reduced their cigarette use or, second, some survivors were infrequent/sporadic smokers (i.e., "social smokers") who considered themselves to be a smoker but only used cigarettes in specific situations.
Misclassification was significantly higher in younger survivors who may not identify as a "smoker" secondary to inconsistent smoking patterns or less confidence in reporting smoking status to clinicians. Impressively, marijuana use increased the odds of misclassification. Among participants, 81% of self-reported smokers (including past smokers) had ever used marijuana, which is significantly higher than 58% reported in a national survey. 16 Marijuana use by smokers is associated with inferior tobacco cessation outcomes. 17 This study has several limitations. First, self-reported smoking and serum data were not uniformly collected together (median intervals = 30 days; range = 0-185 days). Because cotinine is typically detectable up to 7 days following tobacco exposure, 18 longer intervals between survey completion and serum collection may bias misclassification rates, especially for infrequent smokers. Second, the use of modern combustible tobacco (e.g., small cigar and hookah) and electronic nicotine delivery systems (e.g., electronic cigarettes) was not evaluated. There is a particular public health concern about increases in hookah and e-cigarette use. A recent national study found that 2.8% of U.S. cancer survivors are current e-cigarette users, and 6.3%
were past users; additionally, 15.6% of the current smokers are current e-cigarette users. 19 Another national study suggests that 3.9% of U.S. adults aged 18-40 years are lifetime hookah users. 20 Using these TA B L E 1 Misclassification rate and validity for the self-reported cigarette smoking method 
